Baseline angiographic characteristics of the non-dilated lesions in the intention to treat (n = 4084) and per protocol population (n = 3356)
| Intention to treat | Per protocol | |||
|---|---|---|---|---|
| Variable | Nisoldipine (n=1977) | Placebo (n=2107) | Nisoldipine (n=1593) | Placebo (n=1763) |
| Values are mean (SD) or %. | ||||
| Differences between treatment groups are non-significant. | ||||
| DS, diameter stenosis; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; MLD, minimum luminal diameter; RCA, right coronary artery. | ||||
| MLD (mm) | 1.94 (0.68) | 1.95 (0.65) | 1.94 (0.67) | 1.96 (0.65) |
| DS (%) | 36.8 (11.7) | 36.5 (11.3) | 36.6 (11.5) | 36.2 (11.2) |
| Location (%) | ||||
| LAD | 31 | 32 | 30 | 32 |
| LCx | 29 | 28 | 30 | 28 |
| RCA | 38 | 37 | 38 | 37 |
| Other | 3 | 3 | 2 | 3 |
| Degree of stenosis (%) | ||||
| ≤20% | 3 | 3 | 3 | 3 |
| >20%, ≤50% | 85 | 86 | 86 | 86 |
| >50% | 12 | 12 | 12 | 11 |